Isoacné

Isotretinoin, the active ingredient in Isoacné, is a retinoid presented as an oral formulation for oral use. It treats severe nodular acne and acne vulgaris in patients who have not responded adequately to other therapies.

GNH USA supplies Isoacné as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isoacné (isotretinoin) belongs to the retinoid class and is indicated for severe forms of acne.

Severe nodular acne: markedly reduces inflammatory lesions and prevents scarring. Acne vulgaris: decreases both inflammatory and non‑inflammatory lesions when other treatments fail. Recalcitrant moderate acne: may be considered for patients unresponsive to conventional oral antibiotics and topical agents.

Isotretinoin may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Dry skin and mucous membranes (xerosis, cheilitis). - Nasal crusting or epistaxis. - Photosensitivity with increased sunburn risk. - Elevated liver enzymes. - Mild hypertriglyceridemia. - Headache or transient visual disturbances.

Serious or Rare Side Effects: - Severe depression or suicidal ideation. - Inflammatory bowel disease flare. - Teratogenic effects causing fetal malformations. - Pancreatitis associated with marked hypertriglyceridemia. - Severe hyperlipidemia requiring medical intervention. - Rare cases of pseudotumor cerebri.

Before initiating therapy, clinicians should evaluate several safety considerations.

Pregnancy: contraindicated; strict contraception required due to teratogenic risk. Liver function: obtain baseline tests and monitor periodically for hepatotoxicity. Lipid profile: assess baseline triglycerides and monitor during treatment. Vitamin A intake: avoid concomitant vitamin A supplements to prevent additive toxicity. Contraception: use two reliable methods throughout treatment and for one month after cessation. Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Isotretinoin can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Tetracycline antibiotics: increased risk of intracranial hypertension. - Vitamin A supplements: additive retinoid toxicity. - Systemic corticosteroids: may diminish isotretinoin effectiveness.

Moderate Interactions (Monitor Closely): - Oral contraceptives: possible reduction in contraceptive efficacy; advise additional barrier methods. - Hepatotoxic drugs (e.g., methotrexate, azathioprine): monitor liver enzymes closely.